Date published: 2026-5-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

SgK269 Inhibitors

SgK269 is a serine/threonine kinase involved in various signaling pathways, including those related to cellular stress responses, migration, and cytoskeletal organization. The kinase is a part of the broader family of kinases that respond to environmental and cellular cues, playing a role in modulating cellular architecture and response to stress. Its activation and function are tied to the integration of signals from multiple upstream pathways such as the MAPK and PI3K-AKT pathways, which are critical for the regulation of cell growth, survival, and adaptation to stress.

Due to the complex nature of kinase regulation and the absence of direct inhibitors specifically targeting SgK269, the focus shifts to indirect inhibition through modulation of upstream and related pathways. These pathways are rich with potential therapeutic targets, where inhibition can lead to decreased SgK269 activity. The indirect approach involves using kinase inhibitors that are well characterized and widely studied, providing a broad inhibition spectrum that affects multiple pathways and, consequently, the activity of SgK269. This method reflects a strategic attempt to control SgK269 activity by curbing the signaling cascades that activate it or are influenced by it. Such an approach not only highlights the interconnected nature of cellular signaling networks but also illustrates the challenges in targeting a single kinase without affecting the broader cellular environment.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor, Wortmannin effectively shuts down the PI3K-AKT pathway, leading to decreased kinase activity including that of SgK269, which is crucial for multiple cell signaling functions.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

By inhibiting MEK1/2, PD98059 blocks the MAPK/ERK pathway, which is essential for the full activation of downstream kinases including SgK269, impacting its regulatory functions.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that affects downstream signaling pathways related to cell growth and survival, which are also influenced by SgK269 activity, particularly in the context of its role in cellular stress responses.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, impacting the stress-activated protein kinase pathway. JNK pathway inhibition can modulate other kinases including SgK269 by altering stress response mechanisms in cells.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF inhibitor that also impacts several other kinases and receptors, including those involved in pathways where SgK269 is active. This broad inhibition reduces the signaling capabilities of SgK269.

PP242

1092351-67-1sc-301606A
sc-301606
1 mg
5 mg
$57.00
$172.00
8
(1)

Targets mTORC1 and mTORC2, crucial for AKT signaling and downstream effects that can involve SgK269; by inhibiting these complexes, PP242 diminishes the functional reach of SgK269 in cells.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Src family kinase inhibitor, affects multiple signaling pathways, potentially including those where SgK269 is active, by broadly reducing kinase-driven signal transduction.

PIK-75, hydrochloride

372196-77-5sc-296089
sc-296089A
1 mg
5 mg
$29.00
$124.00
(1)

Highly selective PI3Kα inhibitor, also impacts other PI3K isoforms to a lesser extent, thereby reducing AKT activation and subsequent effects on kinases such as SgK269 involved in similar pathways.

ZSTK 474

475110-96-4sc-475495
5 mg
$75.00
(0)

Potent PI3K inhibitor, effectively reduces PI3K/AKT pathway signaling, decreasing the overall activity of downstream kinases including SgK269, especially in processes like cell growth and survival.